Patents by Inventor Guy Nicolas

Guy Nicolas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7226492
    Abstract: Tungsten-based alloy material sintered at a high sintering power that may contain additive elements soluble in the nickel and selected from the group constituted, for example, by rhenium, molybdenum, tantalum, niobium, vanadium or a mixture of these, wherein, after sintering in liquid phase at a temperature of around 1500° C., it has: a two-phased ?-? microstructure that is fully densified, has no porosities or has negligible porosities of a low mean grain size (L?) and a contiguity (C??) that is very low with respect to the size of the tungsten crystals, and a dispersion of micro-oxides with no loss of ductility properties.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: June 5, 2007
    Inventors: Pascal Mahot, Guy Nicolas, Marc Voltz
  • Patent number: 6914134
    Abstract: The invention relates to the sequence of the capsid gene and a corresponding cDNA sequence, of a dominant FCV strain called FCV 431. It also relates to the sequence of the capsid gene as well as the cDNA sequence of a complementary strain called G1. The cDNA sequences may be incorporated into expression vectors for the preparation of immunogenic preparations and of recombinant or subunit vaccines allowing vaccination against feline calicivirosis.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: July 5, 2005
    Assignee: Merial
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Sylvie Claudine Brunet
  • Publication number: 20050103158
    Abstract: Tungsten-based alloy material sintered at a high sintering power that may contain additive elements soluble in the nickel and selected from the group constituted, for example, by rhenium, molybdenum, tantalum, niobium, vanadium or a mixture of these, wherein, after sintering in liquid phase at a temperature of around 1500° C., it has: a two-phased ?-? microstructure that is fully densified, has no porosities or has negligible porosities of a low mean grain size (L?) and a contiguity (C??) that is very low with respect to the size of the tungsten crystals, and a dispersion of micro-oxides with no loss of ductility properties.
    Type: Application
    Filed: September 20, 2002
    Publication date: May 19, 2005
    Applicant: Cime Bocuze
    Inventors: Pascal Mahot, Guy Nicolas, Marc Voltz
  • Publication number: 20030109033
    Abstract: The invention relates to the sequence of the capsid gene and a corresponding cDNA sequence, of a dominant FCV strain called FCV 431. It also relates to the sequence of the capsid gene as well as the cDNA sequence of a complementary strain called G1. The cDNA sequences may be incorporated into expression vectors for the preparation of immunogenic preparations and of recombinant or subunit vaccines allowing vaccination against feline calicivirosis.
    Type: Application
    Filed: July 30, 2002
    Publication date: June 12, 2003
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Sylvie Claudine Brunet
  • Patent number: 6541458
    Abstract: The invention relates to the sequence of the capsid gene and a corresponding cDNA sequence, of a dominant FCV strain called FCV 431. It also relates to the sequence of the capsid gene as well as the cDNA sequence of a complementary strain called G1. The cDNA sequences may be incorporated into expression vectors for the preparation of immunogenic preparations and of recombinant or subunit vaccines allowing vaccination against feline calicivirosis.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: April 1, 2003
    Assignee: Merial
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Sylvie Claudine Brunet
  • Patent number: 6387376
    Abstract: The recombinant live vaccine comprises, as vector, a feline herpesvirus comprising and expressing at least one nucleotide sequence encoding a polypeptide, this sequence being inserted into the ORF5 and/or ORF2 sites. Polyvalent vaccine formula and feline herpesvirus DNA fragments.
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: May 14, 2002
    Assignee: Merial
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Michel Albert Emile Riviere
  • Patent number: 6074649
    Abstract: The recombinant live vaccine comprises, as vector, a feline herpesvirus comprising and expressing at least one nucleotide sequence encoding a polypeptide, this sequence being inserted into the ORF5 and/or ORF2 sites. Polyvalent vaccine formula and feline herpesvirus DNA fragments.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: June 13, 2000
    Assignee: Merial
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Michel Albert Emile Riviere
  • Patent number: 4960563
    Abstract: The invention relates to a process for the production of a heavy tungsten-nickel-iron alloy with high mechanical characteristics comprising the steps of using powders of each of the elements of a FISHER diameter between 1 and 15 .mu.m, mixing the powders in proportions corresponding to the composition of the desired alloy, compressing the powders in the form of compacted items, sintering the compacted items at a temperature of between 1490 and 1650.degree. C. for 2 to 5 hours, treating the sintered compacted items under vacuum at between 1000.degree. and 1300.degree. C., and subjecting the compacted items after treatment under vacuum to at least three cycles of operation, each cycle comprising a working step followed by a heat treatment.
    Type: Grant
    Filed: March 7, 1990
    Date of Patent: October 2, 1990
    Assignee: Cime Bocuze
    Inventor: Guy Nicolas
  • Patent number: 4938799
    Abstract: The invention relates to heavy tungsten-nickel-iron alloys with high mechanical characteristics and a specific gravity between 15.6 and 18. The alloys include a tungsten .alpha.-phase in the shape of butterfly wings with dislocation cells of dimensions between 0.1 and 1 .mu.m, and a nickel-iron bonding .gamma.-phase having a mean free path of less than 15 .mu.m and an Ni/Fe ratio greater than or equal to 2.
    Type: Grant
    Filed: October 5, 1988
    Date of Patent: July 3, 1990
    Assignee: Cime Bocuze
    Inventor: Guy Nicolas
  • Patent number: 4931252
    Abstract: A process for reducing disparities of mechanical properties in tungsten-nickel-iron alloys containing in % by weight 85 to 99% of tunsten, 1 to 10% of iron, the alloys being obtained from tungsten, nickel and iron powders which have the same or different grain diameter, shape and size distribution, which entails simultaneously adding an effective amount of each of cobalt and manganese powders to tungsten powder or to a mixture of tungsten, nickel and iron powders.
    Type: Grant
    Filed: May 27, 1988
    Date of Patent: June 5, 1990
    Assignee: Cime Bocuze
    Inventors: Laurent Brunisholz, Guy Nicolas
  • Patent number: D522588
    Type: Grant
    Filed: July 7, 2004
    Date of Patent: June 6, 2006
    Assignee: UPTEC, naanloze vennootschap
    Inventor: Jean-Mario Guy Nicolas Bockstael